Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Celularity (CELU) Enterprise Value (2020 - 2026)

Celularity (CELU) has disclosed Enterprise Value for 6 consecutive years, with -$6.2 million as the latest value for Q4 2025.

  • For Q4 2025, Enterprise Value fell 736.72% year-over-year to -$6.2 million; the TTM value through Dec 2025 reached -$6.2 million, down 736.72%, while the annual FY2025 figure was -$6.2 million, 736.72% down from the prior year.
  • Enterprise Value hit -$6.2 million in Q4 2025 for Celularity, down from -$120000.0 in the prior quarter.
  • Across five years, Enterprise Value topped out at -$211.0 in Q2 2021 and bottomed at -$72.7 million in Q3 2021.
  • Average Enterprise Value over 5 years is -$13.8 million, with a median of -$1.4 million recorded in 2024.
  • Year-over-year, Enterprise Value plummeted 18007482.94% in 2022 and then surged 99.36% in 2023.
  • Celularity's Enterprise Value stood at -$37.2 million in 2021, then soared by 62.5% to -$14.0 million in 2022, then skyrocketed by 98.37% to -$227000.0 in 2023, then tumbled by 225.11% to -$738000.0 in 2024, then crashed by 736.72% to -$6.2 million in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$6.2 million, -$120000.0, and -$863000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.